Below you can find consensus from equity research analysts that currently cover Fluidra's stock (updated on a monthly basis).
FY 2024 (in €M):
| Metric | Min | Max | Average | Contr. |
|---|---|---|---|---|
| Sales | 2,007 | 2,135 | 2,081 | 16 |
| Adjusted EBITDA | 441 | 480 | 468 | 15 |
| Adjusted EBITA | 373 | 388 | 381 | 5 |
| Cash Net Profit | 206 | 232 | 222 | 4 |
| Cash EPS | 1,07 | 1,22 | 1,17 | 6 |
| Net Working Capital | 345 | 497 | 393 | 12 |
| Net Debt | 1,041 | 1,169 | 1,103 | 14 |
FY 2025 (in €M):
| Metric | Min | Max | Average | Contr. |
|---|---|---|---|---|
| Sales | 2,087 | 2,259 | 2,190 | 15 |
| Adjusted EBITDA | 477 | 535 | 513 | 14 |
| Adjusted EBITA | 422 | 445 | 429 | 5 |
| Cash Net Profit | 254 | 268 | 264 | 4 |
| Cash EPS | 1,34 | 1,43 | 1,38 | 6 |
| Net Working Capital | 369 | 527 | 416 | 12 |
| Net Debt | 858 | 1,129 | 990 | 13 |
* Data as of 26.04.2024
Notes:
- A total of 19 analysts cover Fluidra. The consensus presented above includes figures from those analysts who have published updated estimates since the company held its FY2023 results (16 analysts).
- The metrics compiled above are consistent with Fluidra's reporting metrics. Fluidra does not alter the figures in any way.